N-[(2-chlorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-chlorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-methylphenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine

C109H105Cl2F17N12O5 — CID 167605611

IUPACN-[(2-chlorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-chlorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-methylphenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine
SMILESCc1ccccc1CN(CCOc1ccc(C(F)(F)F)cc1)Cc1cccnc1.Cn1ccnc1CN(CCOc1ccc(C(F)(F)F)cc1)Cc1ccccc1Cl.Cn1ccnc1CN(CCOc1ccc(C(F)(F)F)cc1)Cc1ccccc1F.FC(F)(F)c1ccc(OCCN(Cc2cccnc2)Cc2ccccc2Cl)cc1.Fc1ccccc1CN(CCOc1ccc(C(F)(F)F)cc1)Cc1cccnc1
InChIInChI=1S/C23H23F3N2O.C22H20ClF3N2O.C22H20F4N2O.C21H21ClF3N3O.C21H21F4N3O/c1-18-5-2-3-7-20(18)17-28(16-19-6-4-12-27-15-19)13-14-29-22-10-8-21(9-11-22)23(24,25)26;2*23-21-6-2-1-5-18(21)16-28(15-17-4-3-11-27-14-17)12-13-29-20-9-7-19(8-10-20)22(24,25)26;2*1-27-11-10-26-20(27)15-28(14-16-4-2-3-5-19(16)22)12-13-29-18-8-6-17(7-9-18)21(23,24)25/h2-12,15H,13-14,16-17H2,1H3;2*1-11,14H,12-13,15-16H2;2*2-11H,12-15H2,1H3
InChIKeyKIKLBMUDURLKIJ-UHFFFAOYSA-N
MW2056.99 g/mol
LogP26.48
Rot. Bonds40

About N-[(2-chlorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-chlorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-methylphenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine

N-[(2-chlorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-chlorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-methylphenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine (PubChem CID 167605611) has the molecular formula C109H105Cl2F17N12O5 and a molecular weight of 2056.99 g/mol. Its IUPAC name is N-[(2-chlorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-chlorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-methylphenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine.

Molecular Properties

Compound NameN-[(2-chlorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-chlorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-methylphenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine
PubChem CID167605611
Molecular FormulaC109H105Cl2F17N12O5
Molecular Weight2056.99 g/mol
Exact Mass2054.74
IUPAC NameN-[(2-chlorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-chlorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-methylphenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine
SMILESCc1ccccc1CN(CCOc1ccc(C(F)(F)F)cc1)Cc1cccnc1.Cn1ccnc1CN(CCOc1ccc(C(F)(F)F)cc1)Cc1ccccc1Cl.Cn1ccnc1CN(CCOc1ccc(C(F)(F)F)cc1)Cc1ccccc1F.FC(F)(F)c1ccc(OCCN(Cc2cccnc2)Cc2ccccc2Cl)cc1.Fc1ccccc1CN(CCOc1ccc(C(F)(F)F)cc1)Cc1cccnc1
InChIInChI=1S/C23H23F3N2O.C22H20ClF3N2O.C22H20F4N2O.C21H21ClF3N3O.C21H21F4N3O/c1-18-5-2-3-7-20(18)17-28(16-19-6-4-12-27-15-19)13-14-29-22-10-8-21(9-11-22)23(24,25)26;2*23-21-6-2-1-5-18(21)16-28(15-17-4-3-11-27-14-17)12-13-29-20-9-7-19(8-10-20)22(24,25)26;2*1-27-11-10-26-20(27)15-28(14-16-4-2-3-5-19(16)22)12-13-29-18-8-6-17(7-9-18)21(23,24)25/h2-12,15H,13-14,16-17H2,1H3;2*1-11,14H,12-13,15-16H2;2*2-11H,12-15H2,1H3
InChIKeyKIKLBMUDURLKIJ-UHFFFAOYSA-N
XLogP26.48
TPSA136.66 Ų
H-Bond Donors
H-Bond Acceptors17
Rotatable Bonds40
Heavy Atoms145
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002056.99
LogP ≤ 526.48
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1017

Analyze N-[(2-chlorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-chlorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-methylphenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(2-chlorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-chlorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-methylphenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine?
The IUPAC name of N-[(2-chlorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-chlorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-methylphenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine (CID 167605611) is N-[(2-chlorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-chlorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-methylphenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine.
What is the SMILES notation for N-[(2-chlorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-chlorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-methylphenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine?
The canonical SMILES for N-[(2-chlorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-chlorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-methylphenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine is Cc1ccccc1CN(CCOc1ccc(C(F)(F)F)cc1)Cc1cccnc1.Cn1ccnc1CN(CCOc1ccc(C(F)(F)F)cc1)Cc1ccccc1Cl.Cn1ccnc1CN(CCOc1ccc(C(F)(F)F)cc1)Cc1ccccc1F.FC(F)(F)c1ccc(OCCN(Cc2cccnc2)Cc2ccccc2Cl)cc1.Fc1ccccc1CN(CCOc1ccc(C(F)(F)F)cc1)Cc1cccnc1.
What is the InChIKey of N-[(2-chlorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-chlorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-methylphenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine?
The InChIKey is KIKLBMUDURLKIJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H23F3N2O.C22H20ClF3N2O.C22H20F4N2O.C21H21ClF3N3O.C21H21F4N3O/c1-18-5-2-3-7-20(18)17-28(16-19-6-4-12-27-15-19)13-14-29-22-10-8-21(9-11-22)23(24,25)26;2*23-21-6-2-1-5-18(21)16-28(15-17-4-3-11-27-14-17)12-13-29-20-9-7-19(8-10-20)22(24,25)26;2*1-27-11-10-26-20(27)15-28(14-16-4-2-3-5-19(16)22)12-13-29-18-8-6-17(7-9-18)21(23,24)25/h2-12,15H,13-14,16-17H2,1H3;2*1-11,14H,12-13,15-16H2;2*2-11H,12-15H2,1H3.
What are the key properties of N-[(2-chlorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-chlorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-methylphenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine?
N-[(2-chlorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-chlorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-methylphenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine has a molecular weight of 2056.99 g/mol, XLogP of 26.48, 40 rotatable bonds, 0 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2-chlorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-chlorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-[(1-methylimidazol-2-yl)methyl]-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-fluorophenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine;N-[(2-methylphenyl)methyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethyl)phenoxy]ethanamine is sourced from PubChem (CID 167605611), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).